Covered recipient · General Payments record
ANDREA D WEDDLE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,445.76
- Reported across 146 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $561.32 | 36 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $373.16 | 25 |
| Novo Nordisk AS | $55.62 | 3 |
| Acerta Pharma LLC | $52.36 | 3 |
| Otsuka America Pharmaceutical, Inc. | $37.67 | 2 |
| Amgen Inc. | $28.22 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.59 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390525 | CMS |
| ABBVIE INC. | $5.93 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390527 | CMS |
| ABBVIE INC. | $2.39 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390529 | CMS |
| ABBVIE INC. | $22.46 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390531 | CMS |
| ABBVIE INC. | $11.57 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390533 | CMS |
| ABBVIE INC. | $30.13 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390535 | CMS |
| ABBVIE INC. | $8.48 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390537 | CMS |
| ABBVIE INC. | $20.73 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390539 | CMS |
| ABBVIE INC. | $5.29 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390541 | CMS |
| ABBVIE INC. | $12.66 | 04/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390543 | CMS |
| ABBVIE INC. | $11.14 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390545 | CMS |
| ABBVIE INC. | $23.88 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390547 | CMS |
| ABBVIE INC. | $9.66 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390549 | CMS |
| ABBVIE INC. | $25.21 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390551 | CMS |
| ABBVIE INC. | $30.01 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390553 | CMS |
| ABBVIE INC. | $7.84 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390555 | CMS |
| ABBVIE INC. | $18.26 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390557 | CMS |
| ABBVIE INC. | $8.48 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390559 | CMS |
| ABBVIE INC. | $8.93 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390561 | CMS |
| ABBVIE INC. | $25.32 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390563 | CMS |
| ABBVIE INC. | $18.01 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390565 | CMS |
| ABBVIE INC. | $25.70 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390567 | CMS |
| ABBVIE INC. | $4.79 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390569 | CMS |
| ABBVIE INC. | $8.95 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390571 | CMS |
| ABBVIE INC. | $5.75 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108390573 | CMS |
| Amgen Inc. | $14.53 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117715206 | CMS |
| Amgen Inc. | $13.69 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117715208 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.94 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104778968 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.68 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104408017 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.74 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104658781 | CMS |
| Novo Nordisk Inc | $21.46 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100577892 | CMS |
| Novo Nordisk Inc | $18.13 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100477548 | CMS |
| Novo Nordisk Inc | $16.03 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100434985 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.60 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119211475 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.07 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119211477 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.29 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153460709 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.